Chart calendar Daiichi Sankyo Company, Limited
Upcoming events on Daiichi Sankyo Company, Limited
Past events on Daiichi Sankyo Company, Limited
03/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No TPS8126 |
03/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No 8593 |
03/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No 8617 |
03/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No 8543 |
03/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No TPS5625 |
03/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No 6037 |
03/06/2024 12:00 | American Society of Clinical Oncology Meeting |
03/06/2024 07:00 | American Society of Clinical Oncology Meeting |
02/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No TPS1120 |
02/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No 4565 |
02/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No 1025 |
02/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No1023 |
02/06/2024 13:30 | American Society of Clinical Oncology Meeting - Abstract No LBA1000 |
01/06/2024 21:00 | American Society of Clinical Oncology Meeting - Abstract No 1006 |
01/06/2024 21:00 | American Society of Clinical Oncology Meeting - Abstract No1009 |
01/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No TPS4180 |
01/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No 4090 |
01/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No TPS3165 |
01/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No TPS2091 |
01/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No TPS3164 |
Annual results
Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 981 793 976 149 0.58% | 962 516 968 330 -0.6% | 1 044 900 1 034 624 0.99% | 1 278 478 1 267 390 0.87% | 1 601 700 1 580 154 1.36% | 1 789 745 |
EBITDA Million JPY | Released Forecast Spread | 191 411 185 259 3.32% | 121 177 128 862 -5.96% | 131 270 155 362 -15.51% | 188 369 191 173 -1.47% | 271 234 251 664 7.78% | 306 408 |
EBIT Million JPY | Released Forecast Spread | 138 800 139 032 -0.17% | 63 795 68 156 -6.4% | 73 000 96 404 -24.28% | 120 580 134 276 -10.2% | 211 600 191 646 10.41% | 242 609 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 141 164 140 335 0.59% | 74 124 77 118 -3.88% | 73 500 97 839 -24.88% | 126 854 136 479 -7.05% | 237 200 200 698 18.19% | 253 683 |
Net income Million JPY | Released Forecast Spread | 129 074 113 210 14.01% | 75 958 58 345 30.19% | 67 000 70 466 -4.92% | 109 188 102 307 6.73% | 200 700 167 864 19.56% | 201 280 |
EPS JPY | Released Forecast Spread | 66,4 58,7 13.2% | 39,2 30,2 29.84% | 34,9 36,5 -4.27% | 57,0 53,1 7.33% | 105 87,3 19.9% | 107 |
Announcement Date | 27/04/20 | 27/04/21 | 27/04/22 | 27/04/23 | 25/04/24 | - |
Quarterly results
Fiscal Period | March | 2020 S2 | 2021 S1 | 2022 S1 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 502 220 498 959 0.65% | 480 168 477 000 0.66% | 529 965 518 750 2.16% | 233 933 227 144 2.99% | 280 317 261 563 7.17% | 327 480 285 928 14.53% | 607 797 585 700 3.77% | 340 479 343 167 -0.78% | 330 202 314 825 4.88% | 350 835 330 936 6.01% | 375 465 369 692 1.56% | 726 300 709 573 2.36% | 446 925 406 519 9.94% | 428 431 406 491 5.4% | 407 545 | 425 100 | 808 986 | 477 625 | 477 775 |
EBITDA Million JPY | Released Forecast Spread | 114 454 87 200 31.25% | 33 427 40 212 -16.87% | 110 400 | 56 200 | 83 300 | 47 200 | |||||||||||||
EBIT Million JPY | Released Forecast Spread | 52 637 51 087 3.03% | 58 465 50 500 15.77% | 84 742 67 450 25.64% | -50 772 -21 957 -131.24% | 34 382 26 700 28.77% | 61 198 31 939 91.61% | 95 580 80 100 19.33% | 31 551 39 700 -20.53% | -6 551 7 982 -182.07% | 44 032 39 637 11.09% | 51 068 35 618 43.38% | 95 100 68 024 39.8% | 99 488 51 269 94.05% | 17 049 8 828 93.14% | 57 220 | 52 240 | 80 552 | 69 384 | 51 448 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 54 124 54 607 -0.88% | 66 986 52 500 27.59% | 85 955 66 600 29.06% | -52 386 -18 099 -189.44% | 29 415 33 945 -13.35% | 61 850 31 626 95.57% | 91 265 78 500 16.26% | 36 185 55 627 -34.95% | -596 8 254 -107.22% | 52 133 43 082 21.01% | 49 967 8 400 494.85% | 102 100 71 803 42.19% | 97 749 -5 000 2054.98% | 37 354 16 259 129.75% | 61 129 | 49 400 | 86 252 | 68 650 | 49 150 |
Net income Million JPY | Released Forecast Spread | 64 648 51 524 25.47% | 51 667 38 500 34.2% | 62 465 50 000 24.93% | -27 318 -14 049 -94.45% | 18 851 26 679 -29.34% | 39 458 25 026 57.67% | 58 309 60 400 -3.46% | 28 391 42 827 -33.71% | 22 488 4 303 422.65% | 57 013 32 400 75.97% | 39 987 11 201 256.99% | 97 000 58 677 65.31% | 66 558 27 792 139.49% | 37 136 16 199 129.25% | 50 833 | 45 539 | 69 592 | 57 160 | 43 367 |
EPS JPY | Released Forecast Spread | 26,6 19,8 34.19% | 32,6 26,3 23.92% | -10,1 -7,89 -27.63% | 9,84 11,3 -12.69% | 20,6 14,0 47.32% | 30,4 31,7 -4.04% | 14,8 19,8 -25.3% | 11,7 0,90 1208.17% | 29,7 16,2 83.75% | 20,9 20,5 1.69% | 50,6 34,3 47.49% | 34,7 17,4 99.95% | 19,4 7,56 156.2% | 20,4 | 24,8 | 23,8 | 30,9 | 31,9 | |
Announcement Date | 27/04/20 | 30/10/20 | 29/10/21 | 27/04/22 | 29/07/22 | 31/10/22 | 31/10/22 | 31/01/23 | 27/04/23 | 31/07/23 | 31/10/23 | 31/10/23 | 31/01/24 | 25/04/24 | - | - | - | - | - |
Past sector events for Daiichi Sankyo Company, Limited
21/06/2024 16:28 | DEVA HOLDING: Q1 2024 Earnings Release |
13/06/2024 22:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
11/06/2024 06:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
07/06/2024 11:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
07/06/2024 10:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |